Industries > Pharma > Generic Drugs Market Forecast 2018-2028

Generic Drugs Market Forecast 2018-2028

Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico

PUBLISHED: 25 April 2018
PAGES: 254
PRODUCT CODE: PHA0305

Clear
WOOCS 2.2.1

The generic drugs market is estimated at $257.3bn in 2017 and is expected to grow at a CAGR of 7.9% from 2017 to 2028. The generic drugs market is expected to grow at a CAGR of 7.2% in the second half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 254-page report you will receive 66 tables and 84 figures– all unavailable elsewhere.

The 254-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Generic Drugs Market forecasts from 2018-2028

• Generic Drugs Regional Market and National Market forecasts from 2018-2028, covering:
• North America: US & Canada
• Europe: Germany, UK, France, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, Australia, India, China, South Korea, Rest of Asia-Pacific
• Middle East & Africa: South Africa, Saudi Arabia, U.A.E, Rest of Middle East & Africa
• Latin America: Brazil, Argentina, Mexico, Rest of Latin America

Generic Drugs Market Forecast 2018-2028

• SWOT Analysis and Porter’s Five Forces Analysis of the generic drugs market.

• Assessment of selected leading companies that hold major market shares in the generic drugs market.
• Teva
• Novartis (Sandoz)
• Allergan
• Mylan
• Pfizer
• Abbott
• Sun Pharma
• Aspen
• Fresenius Kabi
• Sanofi
• Dr. Reddy’s Laboratories
• Apotex

Visiongain’s study is intended for anyone requiring commercial analyses for the Generic Drugs Market. You find data, trends and predictions.

Buy our report today Generic Drugs Market Forecast 2018-2028: Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Generic Drugs Market Forecast 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Generic Drugs Market Forecast 2018-2028


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories